ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 117 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 1.25 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $2,172,000 | +70.6% | 115,142 | +6.5% | 0.00% | +100.0% |
| Q2 2019 | $1,273,000 | -13.5% | 108,154 | +0.3% | 0.00% | -33.3% |
| Q1 2019 | $1,471,000 | +46.8% | 107,797 | +10.3% | 0.00% | +50.0% |
| Q4 2018 | $1,002,000 | +9.2% | 97,762 | +77.3% | 0.00% | 0.0% |
| Q3 2018 | $918,000 | -11.4% | 55,138 | -15.9% | 0.00% | 0.0% |
| Q2 2018 | $1,036,000 | +29.5% | 65,588 | +4.1% | 0.00% | 0.0% |
| Q1 2018 | $800,000 | +13.6% | 62,986 | +2.5% | 0.00% | +100.0% |
| Q4 2017 | $704,000 | -19.5% | 61,446 | -13.9% | 0.00% | -50.0% |
| Q3 2017 | $874,000 | +24.3% | 71,334 | +16.1% | 0.00% | 0.0% |
| Q2 2017 | $703,000 | -40.3% | 61,416 | +8.5% | 0.00% | -33.3% |
| Q1 2017 | $1,177,000 | +4.3% | 56,591 | +4.3% | 0.00% | 0.0% |
| Q4 2016 | $1,128,000 | -33.4% | 54,254 | +5.0% | 0.00% | -40.0% |
| Q3 2016 | $1,693,000 | +54.0% | 51,649 | +17.3% | 0.01% | +66.7% |
| Q2 2016 | $1,099,000 | +86.3% | 44,025 | +82.9% | 0.00% | +50.0% |
| Q1 2016 | $590,000 | -24.1% | 24,075 | +2.3% | 0.00% | -33.3% |
| Q4 2015 | $777,000 | +15.5% | 23,525 | +14.5% | 0.00% | +50.0% |
| Q3 2015 | $673,000 | -28.0% | 20,540 | +16.3% | 0.00% | -33.3% |
| Q2 2015 | $935,000 | +251.5% | 17,655 | +91.4% | 0.00% | +200.0% |
| Q1 2015 | $266,000 | +29.8% | 9,225 | +30.9% | 0.00% | 0.0% |
| Q4 2014 | $205,000 | – | 7,050 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,130 | $40,160,000 | 10.45% |
| Foresite Capital Management II, LLC | 1,586,220 | $21,652,000 | 9.78% |
| DAFNA Capital Management LLC | 571,013 | $7,794,000 | 3.36% |
| Redmile Group, LLC | 8,244,896 | $112,543,000 | 3.29% |
| Lion Point Capital, LP | 1,271,500 | $17,355,000 | 1.57% |
| Palo Alto Investors LP | 1,861,630 | $25,411,000 | 1.06% |
| SAMLYN CAPITAL, LLC | 3,185,983 | $43,488,000 | 1.03% |
| Bellevue Group AG | 1,286,748 | $17,564,000 | 0.97% |
| BB BIOTECH AG | 2,766,008 | $37,756,000 | 0.95% |
| Rock Springs Capital Management LP | 1,560,000 | $21,294,000 | 0.82% |